{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-011433","form_type":"8-K","ticker":"JANX","cik":"0001817713","company_name":"Janux Therapeutics, Inc.","filed_at":"2023-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.738728+00:00","generated_at":"2026-06-17T08:15:36.714599+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Director Peter Thompson to not stand for re-election at Janux 2023 annual meeting","bullets":["Peter Thompson, M.D., informed Janux he will not stand for re-election to the Board at the 2023 annual meeting due to competing commitments.","Dr. Thompson's decision is not the result of any disagreement with the Company on operations, policies, or practices.","No replacement director has been announced as of the filing date."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-011433","json":"https://secwatch.observer/filing/0000950170-23-011433.json","markdown":"https://secwatch.observer/filing/0000950170-23-011433.md","text":"https://secwatch.observer/filing/0000950170-23-011433.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817713/000095017023011433/0000950170-23-011433-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817713/000095017023011433/janx-20230327.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T08:15:36.714599+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1cf8bc3425","claim":"Peter Thompson departed as director at Janux Therapeutics, Inc..","evidence_excerpt":"On March 27, 2023, Peter Thompson, M.D., a director of Janux Therapeutics, Inc. (the “Company”), informed the Company that he does not intend to stand for re-election as a member of the Board of Directors at the Company’s 2023 annual meeting of stockholders as a result of competing commitments.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1817713/000095017023011433/0000950170-23-011433-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"does not intend to stand for re-election"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}